Maj Soueidan on X
There’s some concern that $FSI recently filed shelf and ATM vehicle are going to be a precursor to dilution. Well, if you believe the verbiage on the Q2 Earnings Call, they’re not👇 “is intended to remain unused unless an unusually compelling acquisition appears, reducing one potential overhang.” The CEO was pretty adamant about this. My “Spidey radar senses” put that statement at about an 85% credibility reading. We have to remember that the company has an idle pharmacy packaging asset that needs some investment to bring it up to par. I believe they had bought the asset out of a distressed asset sale.